Sign in
6-K

Report of Foreign Issuer

Evaxion A/S Filed Acc 0001171843-26-007102

Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting

  • The data further validate the potential of EVX-04 as an off-the-shelf therapeutic vaccine for acute myeloid leukemia

From the SEC's structured data for this filing